CYFANTIR

Serial Number 85155461
606

Registration Progress

Application Filed
Oct 18, 2010
Under Examination
Oct 25, 2011
Approved for Publication
Aug 30, 2011
Published for Opposition
Aug 30, 2011
Registered

Basic Information

Serial Number
85155461
Filing Date
October 18, 2010
Published for Opposition
August 30, 2011
Abandonment Date
December 1, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 1, 2014
Classes
005

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
50 Northern Avenue
Boston, MA 02210

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 606

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Cambridge, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Steven A. Abreu

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description
Dec 1, 2014 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Dec 1, 2014 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 6, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 5, 2014 EX5G S SOU EXTENSION 5 GRANTED
Apr 23, 2014 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 23, 2014 EXT5 S SOU EXTENSION 5 FILED
Jan 14, 2014 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 14, 2014 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 13, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 12, 2013 EX4G S SOU EXTENSION 4 GRANTED
Oct 25, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 25, 2013 EXT4 S SOU EXTENSION 4 FILED
May 10, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 9, 2013 EX3G S SOU EXTENSION 3 GRANTED
Apr 25, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 25, 2013 EXT3 S SOU EXTENSION 3 FILED
Oct 26, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2012 EX2G S SOU EXTENSION 2 GRANTED
Oct 24, 2012 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 23, 2012 EXT2 S SOU EXTENSION 2 FILED
Apr 26, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 24, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 24, 2012 EXT1 S SOU EXTENSION 1 FILED
Apr 24, 2012 EX1G S SOU EXTENSION 1 GRANTED
Oct 25, 2011 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 30, 2011 PUBO A PUBLISHED FOR OPPOSITION
Aug 30, 2011 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2011 ALIE A ASSIGNED TO LIE
Jul 27, 2011 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 6, 2011 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jul 6, 2011 GNEA O EXAMINERS AMENDMENT E-MAILED
Jul 6, 2011 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 6, 2011 XAEC I EXAMINER'S AMENDMENT ENTERED
Jul 6, 2011 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2011 DOCK D ASSIGNED TO EXAMINER
Jan 26, 2011 CNRT R NON-FINAL ACTION WRITTEN
Jan 26, 2011 GNRT F NON-FINAL ACTION E-MAILED
Jan 26, 2011 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 22, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2010 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cystic fibrosis, viral diseases, bacterial infections, cancer, autoimmune diseases, inflammatory diseases, neurological disorders and epilepsy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005